Choose another country to see content specific to your location
//Select CountryHave a requirement or need some help? Contact us to find out how we can help you.
Webinar
After years of negotiations, the EU’s long-awaited EU Regulation 2017/745 on Medical Devices has been published, replacing the older Medical Devices Directive (93/42/EEC) and Active Implantable Medical Devices Directive (90/385/EEC).
The new regulation came into effect in May 2017 and dramatically changes the conformity assessment process and post-market requirements for medical devices. With the transition period now well underway, manufacturers of products for the European market – regardless of whether they are high- or low-risk devices – must ensure familiarity and compliance with 2017/745.
The key differences between the new regulation and the directives it replaces
How these changes particularly impact high-risk cardiovascular devices
Changes to device classifications and conformity assessment routes
Details of increased clinical and PMS requirements, particularly for high-risk and implantable devices.
How to ensure a smooth transition to MDR certification
Global Director – Cardiovascular Focus Team, TÜV SÜD Ltd, UK
Giovanni has nearly two decades of experience in the medical devices field. His professional experience includes more than 8 years with the two largest EU Notified Bodies and roles in the R&D departments of Sorin and Fresenius Medical Care.
He holds a degree in mechanical engineering from the Polytechnic University of Turin.
Related Services: Cardiovascular Medical Devices | Medical Device Regulation (MDR) | EU In Vitro Diagnostic Medical Device Regulation (IVDR)
Select Your Location
Global
TÜV SÜD Global
Asia
Europe
Austria
Belgium
Bosnia and Herzegovina
Croatia
Czech Republic
Denmark
France
Germany
Hungary
Italy
Netherlands
Poland
Romania
Slovakia
Slovenia
Spain
Sweden
Switzerland
Turkey
United Kingdom